Evidence map›Paper›PMID 38020493›Full record

ArticleBMJ surgery, interventions, & health technologies2023

Cardiac coronary tomography angiography (CCTA) use across geographical regions in the USA and the UK: a cross-sectional study.

Bryana Banashefski, Robin Ji, Sanket S Dhruva, John Neuhaus, Rita F Redberg

Abstract read
In one paragraph

Article in BMJ surgery, interventions, & health technologies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bryana BanashefskiIcahn School of Medicine at Mount Sinai, New York, New York, USA.
Robin JiDepartment of Medicine, University of California School of Medicine, San Francisco, California, USA.
Sanket S DhruvaDepartment of Medicine, University of California School of Medicine, San Francisco, California, USA.ORCID 0000-0003-0674-2032
John NeuhausDepartment of Epidemiology & Biostatistics, University of California School of Medicine, San Francisco, California, USA.
Rita F RedbergDepartment of Medicine, University of California School of Medicine, San Francisco, California, USA.ORCID 0000-0001-6281-0250

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Increased use of CT imaging has been identified as a key component of unsustainable rising healthcare costs in the USA and globally. Understanding evidence and its relation to imaging coverage policies can help identify patterns of variation to better inform high value care initiatives. This cross-sectional study evaluates regional differences in US utilisation of cardiac coronary tomography angiography (CCTA) and compares use in the USA and England. Design: We determined differences in CCTA order rates by US Medicare region and compared order rates in the US and England, compared CT scanner prevalence in the USA and UK, and reviewed the CCTA coverage policies for each region. Setting: The US and the UK. Participants: Medicare Coverage Database; Medicare 2018 Part B data; National Health Services 2018 data. Interventions: CCTA orders, CT scanner prevalence. Main outcome measures: CCTA orders per beneficiary, CT scanner prevalence, CCTA policy variation. Results: We found that CCTA coverage policies are more permissive in the UK compared with the USA. However, CT scanner prevalence per beneficiary is four times greater in the USA than the UK. There was significant variation in number of CCTA ordered per 100 000 beneficiaries between regions in England and the USA, ranging from 74 to 313 in the US and 57-317 in England. Conclusions: There is significant geographical variation in use of CCTA in both the USA and England, although overall use does not differ significantly between both countries. Similarities in order rates, despite a much higher CT scanner density in the USA, may be related to more permissive guidelines around use of CCTA in the UK. Variation in both countries may also reflect the lack of high-quality clinical outcomes data for use of CCTA, underscoring opportunities for more evidence and evidence-based policy to promote appropriate use of CCTA imaging.

Indexed as

DevicesHealth PolicyHealth Technology

Identifiers

PMID38020493
PMCPMC10660629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.